Tübingen's messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.

The messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.

T1 Esports, HP Tech Ventures and Axiomatic have all invested in an $11.3m round for the company, which plans to now enhance its esports performance analysis system.

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

The Tencent and Lenovo-backed online grocer has confirmed it has closed a $495m round led by China International Capital Corporation.

Sumitomo's Presidio Ventures unit has contributed to the $56.2m in debt and equity financing so far raised by the robot arm developer.

Mingdu Intelligent, backed by three Chinese academic institutions, has increased its funding haul to at least $26m.

Vesigen has attracted Leaps by Bayer to commercialise drug delivery technology invented by Quan Lu at Harvard School of Public Health.

GV had led an oversubscribed series D round for the gene therapy developer that also featured Illumina Ventures and SoftBank Vision Fund II.

Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.